Keywords: further, cancer, deal, merck, kgaa, hot, heels

Further cancer deal for Merck KGaA

Article | 22 December 1998

Print This

Hot on the heels of its agreement with US company ImClone to develop thelatter's lead anticancer agent C225 (Marketletter December 21, 1998), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in